It would send a troubling message that politics will determine which medical technologies Idahoans are allowed to use. | ...
Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.
Three cases became six, then 10, then 12. Here's an inside look at what's been happening to track exposures, test residents ...
The director-general of Australia’s first Centre for Disease Control, which will be at the crux of managing future pandemics, ...
Internet giant Google tipped off authorities that an account in the name of Canadian public-health doctor David Poon had ...
The surge in vaccine litigation is not simply a post-pandemic, temporary issue. It is a deeper erosion of the legal principles that have long supported public health authority.
Former assistant professor of epidemiology, immunology, and infectious disease at the Harvard T.H. Chan School of Public Health and pathology at Harvard Medical School and Brigham and Women’s Hospital ...
Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.
Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...
The American Academy of Pediatrics generally recommends RSV immunization for infants under eight months old born during or entering their first RSV season if their mothers weren’t vaccinated during ...
A UC San Diego study shows that taking a mushroom-derived supplement during COVID-19 vaccination was safe, eased short-term side effects, and supported longer-lasting immune responses, particularly ...
Immunocompromised status remains a significant risk factor for in-hospital mortality in COVID-19, particularly among patients with pneumonia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results